pentobarbital will reduce the level or influence of fentanyl intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Coadministration of fentanyl with CYP3A4 inducers could lead to some decrease in fentanyl plasma concentrations, deficiency of efficacy or, possibly, enhancement of the withdrawal syndrome